XOMOLIX Solution for injection Ref.[2772] Active ingredients: Droperidol

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: Kyowa Kirin Ltd, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom, Tel. +44 (0)1896 664000

Product name and form

Xomolix 2.5 mg/ml solution for injection.

Pharmaceutical Form

Solution for injection.

Clear colourless solution, free from visible particles.

The pH of droperidol solution for injection is 3.0-3.8 and has an osmolarity of approximately 300 milliosmol/kg water.

Qualitative and quantitative composition

Each millilitre of the solution contains 2.5 mg droperidol.

Excipient: sodium <23 mg per ml (see section 4.4 for further details).

For a full list of excipients, see section 6.1.

Active Ingredient Description
Droperidol

Droperidol is a butyrophenone neuroleptic. Its pharmacologic profile is characterised mainly by dopamine-blocking and weak α1-adrenolytic effects. Droperidol is devoid of anticholinergic and antihistaminic activity.

List of Excipients

Mannitol
Tartaric acid
Sodium hydroxide (for pH adjustment)
Water for injections

Pack sizes and marketing

Type I amber glass ampoules containing 1 ml solution for injection, in packs of 10 ampoules.

Marketing authorization holder

Kyowa Kirin Ltd, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom, Tel. +44 (0)1896 664000

Marketing authorization dates and numbers

PL 16508/0036

28.01.2008

Drugs

Drug Countries
XOMOLIX Austria, Spain, Ireland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.